Masimo Corporation (LON:0JZ2)
London · Delayed Price · Currency is GBP · Price in USD 152.08
+5.31 (3.62%)
Jan 22, 2026, 8:56 AM GMT
Masimo Employees
Masimo had 3,600 employees as of December 28, 2024. The number of employees decreased by 200 or -5.26% compared to the previous year.
Employees
3,600
Change (1Y)
-200
Growth (1Y)
-5.26%
Revenue / Employee
451.97K GBP
Profits / Employee
-117.94K GBP
Market Cap
5.73B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 28, 2024 | 3,600 | -200 | -5.26% |
| Dec 30, 2023 | 3,800 | -200 | -5.00% |
| Dec 31, 2022 | 4,000 | 1,800 | 81.82% |
| Jan 1, 2022 | 2,200 | 200 | 10.00% |
| Jan 2, 2021 | 2,000 | 400 | 25.00% |
| Dec 28, 2019 | 1,600 | 100 | 6.67% |
| Dec 29, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 2, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 3, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Spire Healthcare Group | 15,703 |
| Convatec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
Masimo News
- 1 day ago - Clairity Appoints Founder Dr. Connie Lehman as Chief Executive Officer; Joe Kiani Named Chairman of the Board - GlobeNewsWire
- 2 days ago - HARBOR CAPITAL ADVISORS, INC. Sells 333 Shares of Masimo Corp (MASI) - GuruFocus
- 7 days ago - Masimo Corp (MASI) Shares Up 3.34% on Jan 15 - GuruFocus
- 7 days ago - Masimo Stock Declines Despite Solid Preliminary Q4 Revenues - Nasdaq
- 8 days ago - Masimo Corp at JPMorgan Healthcare Conference Transcript - GuruFocus
- 8 days ago - Masimo Corporation (MASI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 10 days ago - Masimo Posts Preliminary Q4, FY25 Results - Nasdaq
- 10 days ago - Masimo Announces Select Preliminary 2025 Financial Results - Business Wire